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Introduction
The GluD2 receptor (also known as delta2 or Gluδ2) and its closely related paralogue GluD1 are classified to the ionotropic glutamate receptor (iGluR) superfamily on basis of sequence similarity to the 16 other known iGluR subunit genes (Araki et al., 1993; Lomeli et al., 1993) .
Like the other iGluR subtypes (i.e. the N-methyl-D-aspartate (NMDA), AMPA and kainate receptors), GluD2 receptors are predominantly localized in the postsynaptic density (PSD) of excitatory synapses in the central nervous system (CNS). GluD2 was previously designated as an 'orphan' iGluR as no endogenous ligands had been identified that could bind and activate the receptor (Araki et al., 1993; Lomeli et al., 1993) . D-Ser and glycine have now been identified as ligands for GluD2 (Naur et al., 2007) . X-ray crystal structures of the isolated GluD2 ligand binding domain (LBD) show that ligand-binding to the clamshell-shaped LBD induces a closedcleft conformation similar to those observed for NMDA receptor (NMDAR), AMPA receptor and kainate receptor subtypes (Naur et al., 2007) . Ligand-induced closure of the LBD is the initial conformational change that triggers ion channel gating in NMDA, AMPA, and kainate receptors, but ligand binding to the GluD2 LBD does not promote gating of the transmembrane ion channel when GluD2 is expressed as a homomeric tetramer. Thus, by its lack of ionotropic activity, the function of the GluD2 receptor in excitatory transmission appears to be fundamentally different from other iGluRs.
The role of GluD2 in the CNS is most studied in the cerebellum, where GluD2 receptors are expressed in glutamatergic synapses of the Purkinje-type neurons (Hirai et al., 2003; Yuzaki, 2004; Yuzaki, 2009) . A key role for GluD2 in post-synaptic functions in cerebellar Purkinje neurons, including induction of cerebellar long-term depression (LTD), a form of synaptic plasticity that underlies motor learning, has been demonstrated (Hirai et al., 2003; Yuzaki, 2003) .
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6 Considerable experimental evidence exists that argue against an ionotropic synaptic signaling function of GluD2. For example, it has been demonstrated that transgenic mice carrying GluD2 mutations to abolish ion permeation of through the putative GluD2 ion channel pore have a normal phenotype and show intact cerebellar LTD (Kakegawa et al., 2007) . Still, endogenous DSer binding to GluD2 has been shown to regulate LTD in Purkinje neurons (Kakegawa et al., 2011) . This modulation required the intact intracellular C-terminal domain (CTD) of GluD2, which interacts with a range of scaffolding and signaling proteins. It can be speculated that D-Ser binding to the extracellular LBD may induce conformational changes at the CTD that potentially control GluD2 interactions with intracellular effector proteins required for LTD induction, suggesting a possible metabotropic signaling role of GluD2 conceptually a kin to the recently identified metabotropic component of ligand-mediated NMDA receptor signaling in hippocampal LTD (Nabavi et al., 2013) . In addition to a direct signaling role, the extracellular part of GluD2 binds the protein Cbln1, which is secreted from cerebellar granule cells, and this interaction is essential for synapse integrity between Purkinje cells and cerebellar granule cells in adult mice (Matsuda et al., 2010; Matsuda and Yuzaki, 2011; Miura et al., 2009; Yuzaki, 2010; Yuzaki, 2011) . These data support the idea that GluD2 also has a structural role in synapse formation (Ito-Ishida et al., 2014) .
The realization of an active signaling function of GluD2 prompts development of GluD2-selective ligands that can be used as pharmacological tools to further address the molecular function as well as the cellular mechanisms of the receptor. The lurcher mutant of GluD2 (GluD2 LC ) exhibit spontaneously ion channel activity in the absence of ligand binding (Wollmuth et al., 2000; Zuo et al., 1997) , and a previous study identified several ligands capable (Hansen et al., 2009; Naur et al., 2007) . In the present study, we have characterized a series of new compounds at GluD2 LC . We identify several compounds with potency and activity similar to D-Ser at GluD2 LC , including the kynurenic acid analog 7-CKA. Using X-ray crystallography and isothermal titration calorimetry, we establish the structural and thermodynamic basis of 7-CKA binding at the isolated GluD2 LBD.
This article has not been copyedited and formatted. The final version may differ from this version. DNA constructs, cRNA synthesis and protein expression -Rat cDNA for GluD2 (GenBank number U08256) were provided by Dr. J. Boulter (University of California), and sub-cloned into a modified pCI-neo vector (Promega Corp., Madison, WA) as previously described (Hansen et al., 2009) . cRNA were synthesized in vitro using the mMessage mMachine kit (Applied Biosystems, Austin, TX). For recombinant bacterial expression and purification of the LBD from rat GluD2, the GluD2-S1S2 construct was used as previously described (Naur et al., 2007) . The concentration of protein was determined using the Bradford protein assay.
Electrophysiology -cRNA for rat GluD2 (hereafter GluD2) and GluD2 LC (alanine to serine mutation; GluD2-A754S) were injected into Xenopus laevis oocytes, as previously described (Hansen et al., 2009 Crystallization and structure determination -For crystallization experiments, 7-CKA was added in excess of saturation to a GluD2-LBD protein solution of 6.2 mg/ml in 20 mM HEPES (pH 7.0), 10 mM NaCl, 1 mM EDTA. This gave rise to crystal formation in the test tube within a few days. Crystals were cryoprotected by transferring 1 µl of protein solution containing crystals onto a cover slide and adding glycerol to final concentration of 30% w/v before flash-cooling in liquid nitrogen. A dataset extending to 2.5 Å resolution was obtained at 100 K at the I911-2 beamline at MAX-lab, Lund, Sweden (Table 3 ). The data were indexed and integrated using the diffraction data-integration program iMosflm and scaled using the program Scala in the CCP4 software package (Winn, 2003) . The structure was solved by molecular replacement using the program Phaser implemented in CCP4 and the apo structure of GluD2-LBD (PDB entry 2V3T; molecule A) as search model.
Ab initio calculations on 7-CKA were performed using the B3LYP function (Becke, 1993; Lee et al., 1988) to determine geometries and energies. Two tautomeric states of 7-CKA were built and geometry optimizations were performed with the SVP basis set (Schäfer et al., 1992) .
The Final energies were determined with the TZVPP basis set (Weigend et al., 1998) . All
This article has not been copyedited and formatted. The final version may differ from this version. (Klamt and Schuurmann, 1993 ) with a dielectric constant of 80.
The protein structure was subjected to simulated annealing refinement followed by iterative cycles of model building in Coot (Emsley and Cowtan, 2004) and refinement in CNS (Brunger et al., 1998) and Phenix (Adams et al., 2010) until R work /R free converged. For refinement statistics, see Table 3 . The atomic coordinates of the GluD2-LBD structure in complex with 7-CKA have been deposited in the Protein Data Bank with accession code 5CC2. Degree of domain closure was calculated using DynDom (Hayward and Berendsen, 1998) .
Isothermal titration calorimetry (ITC) -ITC was carried out using a VP-ITC calorimeter from
MicroCal, LLC (Northampton, MA) as previously described (Naur et al., 2007) . Briefly, the calorimeter cell (1.40 ml) was filled with purified GluD2-LBD in ITC buffer (in mM: 100 HEPES, 100 NaCl, 2 KCl, pH 7.5) at 20 °C. For D-Ala, 50 injections of 20 mM ligand solutions in ITC buffer were carried out at 3-min intervals with 3 μ l in the initial injection and 6 μ l in the subsequent injections. β -fluoro-DL-alanine (20 mM in ITC buffer) was titrated with 20 injections of 15 μ l with 3-min intervals into GluD2-LBD solution (1 mg/ml). 7-CKA (1 mM in ITC buffer) was titrated with 3-min intervals and the initial injection of 3 μ l and the remaining of 10 μ l into a 2.5 mg/ml solution of GluD2-LBD. The heat of dilution obtained from injecting the ligand into buffer was subtracted before the fitting process. The data analysis was performed using Origin 7.0 (MicroCal) for ITC by using a single binding-site model. The first data points in the analysis were discarded. The stoichiometry N was fixed to 1 in the fitting process.
This article has not been copyedited and formatted. The final version may differ from this version.
Data analysis -Data were analyzed with the program GraphPad Prism 6.0 (GraphPad Software, San Diego, CA) and the program Clampfit (Axon Instruments, Union City, CA, USA)
software. Composite concentration-response data were fitted to the Hill equation:
where ΔI max is the maximum current in response to the ligand, n H denotes the Hill
is the ligand concentration, and EC 50 is the ligand concentration that produces half-maximum current response. The EC 50 and n H from the individual oocytes were used to calculate the mean and standard error of mean (SEM). For graphical presentation, data sets from individual oocytes were normalized to the maximum current response in the same recording, making it possible to calculate the mean and the SEM for each data point. The averaged data points were then fitted to the Hill equation and plotted together with the resulting curve.
This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Screening of compounds as GluD2 ligands -We have previously found that D-Ser,
glycine, and D-Ala are capable of binding to GluD2. Although these ligands cannot initiate ion permeation in full-length wild-type GluD2 receptors expressed in heterologous systems, they can inactivate the spontaneous currents generated by GluD2 carrying the lurcher mutation (Hansen et al., 2009; Naur et al., 2007) . Thus, we hypothesized that measurement of GluD2 LC current can be used to detect novel ligands for the orthosteric binding site in GluD2. We assembled a library of commercially available analogs of D-Ser and other amino acids (Supplemental Table S1 to S4).
The GluD2 orthosteric binding site is most similar to the glycine binding site of the NMDAR GluN1 subunit, which also binds D-Ser and glycine. Therefore, we speculated that GluN1 ligands might have affinity for GluD2 and we thus included a range of known GluN1 competitive antagonists and structural analogs hereof in the library (Supplemental Table S4 ). We initially screened the activity of the library compounds (91 in total) at GluD2 LC receptors expressed in
Xenopus oocytes using two-electrode voltage-clamp electrophysiology ( Table S1 ). None of these compounds were capable of producing a detectable current response at recombinant wild-type GluD2 expressed in Xenopus oocytes (N = 4-8 oocytes for each compound).
This article has not been copyedited and formatted. The final version may differ from this version. Table 2 ). We also included D-Ala in the ITC analysis. ITC previously has been employed to study ligand binding to isolated LBDs from the AMPA-type iGluR subunit GluA2 (Kasper et al., 2006; Martinez et al., 2014) , GluA4 (Madden et al., 2000) and GluD2 (Naur et al., 2007) . Interestingly, 7-CKA binds GluD2-LBD with the highest affinity among compounds characterized by ITC (10-fold higher K a than D-Ser). Furthermore, 7-CKA has a thermodynamic profile that is very different compared to those of the amino acid ligands β -fluoro-DL-alanine, DThis article has not been copyedited and formatted. The final version may differ from this version. (Kasper et al., 2006; Martinez et al., 2014) . On the basis of this, the observed differences in thermodynamic profiles may indicate that 7-CKA has a different binding mode than β -fluoro-DL-alanine, D-Ser, and glycine, and further suggest that 7-CKA may stabilize a distinctly different LBD conformation than the amino acid ligands.
Structural analysis of 7-CKA bound GluD2-LBD by X-ray crystallography -In order to
determine the binding mode of 7-CKA to GluD2 and the molecular details underlying its different thermodynamic profile, we crystallized GluD2-LBD in complex with 7-CKA. The structure of the 7-CKA-bound GluD2-LBD was determined to 2.5 Å resolution and revealed that the complex crystallizes as a monomer with one GluD2 LBD protomer in the asymmetric unit of the crystal (Table 3 ). The electron density of 7-CKA in the ligand-binding site of the GluD2-LBD is well-defined and allowed unambiguous positioning of the ligand and identification of ligand contacts (Fig. 4) . The structure showed one molecule of 7-CKA bound within the cleft formed by domains D1 and D2 of the clamshell-shaped LBD structure (Fig. 4A, B) . Like D-Ser (Naur et al., 2007) , 7-CKA is anchored to the LBD through a bidentate salt bridge formed between the carboxylate group of 7-CKA and the side chain guanidine group of Arg530 (Fig.   4B, C) . In addition, one carboxylate oxygen atom of 7-CKA forms a hydrogen bond to the backbone nitrogen of Thr525. A hydrogen bond is also seen between the ring nitrogen atom of 7-This article has not been copyedited and formatted. The final version may differ from this version. The results showed that the keto-form had a 12.3 kcal/mol lower energy than the enol-form, supporting the proposed hydrogen bond between the ring NH group and the backbone carbonyl of Ala523 (Fig. 4C) . The carbonyl oxygen atom of 7-CKA forms contacts to the backbone nitrogen of Ala686 and two water molecules. 7-CKA is surrounded by several hydrophobic residues of which the ligand forms optimal stacking with Tyr496 (Fig. 4C ). In addition, two 7-CKA molecules were found to bind to surface residues of GluD2-LBD (see Supplemental Fig.   1 ). Compared to the previously reported structure of the GluD2-LBD in complex with D-Ser (Naur et al., 2007) , there is a striking difference in the degree of cleft opening between domains D1 and D2 of the GluD2-LBD in the 7-CKA bound structure (Fig. 4D) . Relative to the D-Ser induced conformation, the D1 and D2 domain opening of GluD2-LBD in complex with 7-CKA is 19.5 degrees more open. Thus, the 7-CKA induced GluD2-LBD conformation is closer to the apo conformation, which has a domain opening of 29.9 degrees relative to the D-Ser induced conformation.
Crystal structures of isolated LBDs from AMPA and NMDA receptor subunits have found that antagonists unambiguously stabilize LBD conformations with domain opening similar or close to the apo conformation (Pohlsgaard et al., 2011) . By contrast, iGluR agonists induce substantial domain closure, which triggers subsequent conformational changes that lead to channel opening (Armstrong and Gouaux, 2000; Pohlsgaard et al., 2011) . Gouaux, 2003) . That is, ligands that induce full domain closure desensitize AMPA receptors to a higher extent than ligands that induce less closure. The present finding that 7-CKA inactivates GluD2 LC currents less than D-Ser at saturating conditions (Fig. 2C ) may suggest that inactivation of GluD2 LC channel activity is linked to desensitization and is correlated to the degree of domain closure. However, an alternative mechanism could be that 7-CKA inhibits spontaneous GluD2 LC channel opening by stabilizing the LBD in a more open conformation in contrast to D-Ser that inhibits by closing the LBD to promote desensitization. To distinguish between these two mechanism of GluD2 LC channel inhibition by 7-CKA, we introduced an engineered disulfide bond at the interface between two GluD2-LBDs (Naur et al., 2007) . This engineered disulfide This article has not been copyedited and formatted. The final version may differ from this version. , 10 mM D-Ser reduced spontaneous channel activity by 57 ± 3% compared to complete channel block by 100 µM 1-naphthyl acetyl spermine (NASP), whereas 1 mM 7-CKA inhibited GluD2 LC by 27 ± 1% (N = 8) (Fig. 5) . GluD2 LC P528+L789C receptors with crosslinked dimer interface were inhibited 7 ± 1% by 10 mM D -Ser and 12 ± 1% by 1 mM 7-CKA (N = 6). Thus, crosslinking the GluD2 LC dimer interface reduced D-Ser responses by 8.1-fold, whereas 7-CKA responses were modestly reduced by 2.3-fold ( 
Discussion
The identification of a possible ligand-mediated signaling role of the GluD2 receptor through occupancy of the orthosteric binding site suggests that development of selective ligands for this site could be useful tools for studying the poorly understood cellular and molecular function of GluD2 (Hansen et al., 2009; Kakegawa et al., 2011; Orth et al., 2013; Williams et al., 2003; Wollmuth et al., 2000) . Of particular importance is the development of a GluD2 selective antagonist, which could allow further investigation of the role of GluD2 in numerous processes.
As a first step towards the development of new GluD2-selective ligands, we have exploited a focused library to identify ligands that modulate constitutively GluD2 LC channel activity. This Kakegawa et al (2011) found that 7-CKA inhibits LTD induction independently of its activity at NMDARs. However, it should be noted that until the molecular mechanism of GluD2 signaling is identified, it is not possible to test directly if effects of ligand-binding to the orthosteric site are agonistic or antagonistic. Therefore, the suggestion that 7-CKA is a competitive antagonist at GluD2 is highly speculative.
Among the compounds for which EC 50 for GluD2 LC inactivation and K d for binding to the isolated GluD2-LBD was determined, 7-CKA and β -fluoro-DL-alanine were the most potent with EC 50 and K d in the lower micromolar range (Table 1 and 2). The results from our initial screening provide some initial insight into the structure-activity relationship (SAR) that might be of value for future efforts to improve potency. For example, agonist activity at iGluRs in general requires the LBD to adopt a conformation in which the D1 and D2 lobes are near-fully or fully closed around the ligand (Kumar and Mayer, 2013; Pohlsgaard et al., 2011) . This may pose specific limits for the size of the agonist structure that depend on the volume of the ligand binding cavity. The structure of D-Ser bound to GluD2-LBD (Naur et al., 2007) shows the ligand binding pocket of GluD2 to be the smallest in volume among all iGluR LBD structures so far determined with D-Ser completely filling the cavity. The small volume may pose an important size constraint for future design efforts of new GluD2 agonists. Thus, creation of agonists with improved affinity by addition of larger functional groups to the scaffold of the endogenous agonist as has been found possible for analogs of L-glutamate at AMPA (Juknaite et al., 2012; Vogensen et al., 2011) , NMDA (Clausen et al., 2008; Erreger et al., 2005; Hansen et al., 2013) , and kainate (Juknaite et al., 2012; Zhou et al., 1997) Table S1 ). In particular, all substitutions at the α -and β -carbons of DSer lead to loss-of-activity (Supplemental Table S1 ). Furthermore, replacement of the β -hydroxyl with larger polar substituents rendered the ligand inactive (Supplemental Table S1 ). The structure of GluD2-LBD in complex with D-Ser (Naur et al., 2007) shows the hydroxyl group to form a direct interaction with the binding pocket in the form of a hydrogen bond to the hydroxyl-group on Tyr543, and the importance of this interaction for compound potency may be illustrated from the decreased EC 50 observed for D-Ala and 1-aminocyclopropane carboxylic acid (ACPC), in which the methyl hydroxyl side chain of D-Ser is removed or replaced by non-polar cyclopropane ring ( Fig. 2 and Table 1 ).
Several compounds containing the quinoline scaffold of 7-CKA were also tested (Supplemental Table S4 ), allowing some information regarding the 7-CKA pharmacophore to be extracted (Fig. 6 ). Compound 87 differ from 7-CKA only by the absence of a chlorine atom at the 7-position, and induced 5% inactivation when evaluated at a concentration of 1 mM compared to the 59% inactivation produced by a similar concentration of 7-CKA (Fig. 6) , demonstrating a key role of the substituent at the 7-position of the quinoline ring in defining ligand activity. The 7-CKA structure shows the chlorine to be located in a sub-pocket lined by polar side chain moieties of Phe563, Asp742 and Tyr770. Future introduction of other polar substituents with hydrogen bond formation properties may be of interest at this position.
Interestingly, the compounds 78 and 86 also lack chlorine at the 7-position, but have a hydroxyl interesting observation is that compound 76 has activity in the range of 7-CKA (Fig. 6 ).
Compound 76 differ from compound 87 (5% inactivation) only by having an ethoxy substituent instead of ketone in the 4-position. The ethyl moiety to the 4-position oxygen may reach into a hydrophobic sub-pocket lined by Trp741 (Fig. 6B) , which suggest further exploration of alkoxy substituents in the 4-position to be warranted for improvement of potency.
In summary, the present identification and characterization of new ligands for the GluD2 receptor constitute a first step toward development of GluD2-selective ligands that could be used as pharmacological tools to explore the role of GluD2 receptors in the CNS. However, further experimentation aimed at providing a more detailed picture of ligand-binding effects on GluD2 receptor function is required. Such studies might focus on understanding the structural changes that is induced by the binding of different ligands in full-length GluD2, or explore functional effects of new disease-associated human mutations that may be identified in GluD2 (Yuan et al., 2015) .
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f The Ramachandran plot was calculated according to MolProbity (Davis et al., 2007) implemented in Phenix.
